| Biomarker ID | 988 |
| PMID | 23020913 |
| Year | 2012 |
| Biomarker | Zinc α2-glycoprotein (ZAG) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Urine |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: ZAG> 1.13: (6.88 (2.5–18.89) |
| Effect on Pathways | NA |
| Experiment | PCA VS No PCA group |
| Type of Biomarker | Diagnostic |
| Cohort | The urine of 127 consecutive candidates for a transrectal ultrasound prostatic biopsy were selected for this study. Without cancer (n= 56), PIN (n= 29), Prostate Cancer (n= 42) |
| Senstivity | 78.6% |
| Specificity | 60% |
| AUC | 0.68 (95% CI 0.59–0.78) |
| Accuracy | NA |
| Level Of Significance | p=0.05 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |